FDA Approves New Yaz Label Warnings

In a regulatory letter issued yesterday, the FDA approved the use of new warning labels for Yaz birth control. The new warnings advise consumers of the potential risk of serious blood clots, including deep vein thrombosis, from the use of Yaz.
One study, published in a British medical journal last summer, indicated that women using Yaz have a 6.3 times greater chance of developing blood clots than women using other pills that contain levonorgestrel. Other studies, sponsored by Bayer, Yasmine’s manufacturer, have not found such a correlation.

If you have been injured as a result of a defective product, such as a dangerous pharmaceutical product, and need the services of a Boston personal injury attorney to represent you in a products liability case against the pharmaceutical’s manufacturer, call The Law Office of Alan H. Crede at (617)973-6434 to arrange a free consultation.